An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness.
An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness.
复制标题
DOI:
10.1016/j.immuni.2010.11.024
复制
发表时间:
2010-12-14
期刊:
影响因子:
32.4
通讯作者:
Matarese G
中科院分区:
文献类型:
--
作者:
Procaccini C;De Rosa V;Galgani M;Abanni L;Calì G;Porcellini A;Carbone F;Fontana S;Horvath TL;La Cava A;Matarese G
There is a discrepancy between the in vitro anergic state of CD4+CD25hiFoxP3+ regulatory T (Treg) cells and their in vivo proliferative capability. The underlying mechanism of this paradox is unknown. Here we show that the anergic state of Treg cells depends on the elevated activity of the mammalian target of rapamycin-(mTOR)-pathway induced by leptin: a transient inhibition of mTOR with rapamycin, before T-cell-receptor-(TCR)-stimulation, made Treg cells highly proliferative in the absence of exogenous interleukin-2 (IL-2). This was a dynamic and oscillatory phenomenon characterized by an early downregulation of the leptin-mTOR-pathway followed by an increase in mTOR activation necessary for Treg cell expansion to occur. These data suggest that energy metabolism, through the leptin-mTOR-axis, sets responsiveness of Treg cells that use this information to control immune tolerance and autoimmunity.